Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 2
2008 4
2009 2
2012 1
2013 2
2014 3
2015 6
2016 5
2017 3
2018 3
2019 4
2020 6
2021 7
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for median as[au]
Your search for Meziani AS[au] retrieved no results
Five-year follow-up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome.
Vincenten SCC, Mul K, van As D, Jansen JJ, Heskamp L, Heerschap A, van Engelen BGM, Voermans NC. Vincenten SCC, et al. Among authors: van as d. J Cachexia Sarcopenia Muscle. 2023 Aug;14(4):1695-1706. doi: 10.1002/jcsm.13250. Epub 2023 May 23. J Cachexia Sarcopenia Muscle. 2023. PMID: 37218549 Free PMC article.

RESULTS: We included 105 FSHD patients [mean age 54 14 years, median Ricci-score 7 (range 0-10)]. The median change over 5 years' time in the MRI-CoS was 2.0% (range -4.6 to +12.1; P < 0.001). The median change over 5 years' time in clinical outcome measur

RESULTS: We included 105 FSHD patients [mean age 54 14 years, median Ricci-score 7 (range 0-10)]. The median change over 5 yea …
Early Postoperative Results of On-Pump Coronary Endarterectomy: Is Gender a Risk Factor?
Eris C, Engin M, Sunbul SA, As AK, Erdolu B. Eris C, et al. Among authors: as ak. Heart Surg Forum. 2021 Jul 28;24(4):E662-E669. doi: 10.1532/hsf.3929. Heart Surg Forum. 2021. PMID: 34473028
RESULTS: Of the 141 patients who underwent CE combined with on-pump CABG, 95 (67.3%) were male, and median age was 66 years (range 58 to 71.2). Of the 141 patients who underwent isolated on-pump CABG, 99 (70.2%) were males, and median age was 63 years (range 41 to 8 …
RESULTS: Of the 141 patients who underwent CE combined with on-pump CABG, 95 (67.3%) were male, and median age was 66 years (range 58 …
Stereotactic Body Radiotherapy for Primary Prostate Cancer.
Kothari G, Loblaw A, Tree AC, van As NJ, Moghanaki D, Lo SS, Ost P, Siva S. Kothari G, et al. Among authors: van as nj. Technol Cancer Res Treat. 2018 Jan 1;17:1533033818789633. doi: 10.1177/1533033818789633. Technol Cancer Res Treat. 2018. PMID: 30064301 Free PMC article.
In patients with low- to intermediate-risk disease, excellent biochemical relapse-free survival outcomes have been reported, albeit with relatively short median follow-up times. These promising early results, coupled with the enormous potential cost savings and implication …
In patients with low- to intermediate-risk disease, excellent biochemical relapse-free survival outcomes have been reported, albeit with rel …
Oligoprogression in Metastatic, Castrate-Resistant Prostate Cancer-Prevalence and Current Clinical Practice.
Patel PH, Tunariu N, Levine DS, de Bono JS, Eeles RA, Khoo V, Murray J, Parker CC, Pathmanathan A, Reid A, van As N, Tree AC. Patel PH, et al. Among authors: van as n. Front Oncol. 2022 May 17;12:862995. doi: 10.3389/fonc.2022.862995. eCollection 2022. Front Oncol. 2022. PMID: 35656509 Free PMC article.
However, PSA doubling time immediately prior to progression did not predict OPD. Median progression-free survival to oligoprogression versus polyprogression was 16.8 vs. 11.7 months. ...
However, PSA doubling time immediately prior to progression did not predict OPD. Median progression-free survival to oligoprogression …
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer.
Patel PH, Chaw CL, Tree AC, Sharabiani M, van As NJ. Patel PH, et al. Among authors: van as nj. World J Urol. 2019 Dec;37(12):2615-2621. doi: 10.1007/s00345-019-02873-w. Epub 2019 Jul 25. World J Urol. 2019. PMID: 31346760 Free PMC article.
Nine patients were castrate resistant and 42 patient's hormone sensitive at the time of SBRT. Median follow-up was 23 months. Median PFS was 24 months in hormone-sensitive patients and 3 months in castrate-resistant patients. ...CONCLUSIONS: In this study, patients …
Nine patients were castrate resistant and 42 patient's hormone sensitive at the time of SBRT. Median follow-up was 23 months. Medi
Patterns of Failure After Stereotactic Body Radiotherapy to Sacral Metastases.
Ratnakumaran R, van As N, Khoo V, McDonald F, Tait D, Ahmed M, Taylor H, Griffin C, Dunne EM, Tree AC. Ratnakumaran R, et al. Among authors: van as n. Clin Oncol (R Coll Radiol). 2023 May;35(5):339-346. doi: 10.1016/j.clon.2023.01.020. Epub 2023 Feb 3. Clin Oncol (R Coll Radiol). 2023. PMID: 36805131
Common primaries treated included prostate (n = 16), breast (n = 6), lung (n = 3) and renal (n = 3) cancers. The median follow-up was 20 months (interquartile range 13-55 months). ...
Common primaries treated included prostate (n = 16), breast (n = 6), lung (n = 3) and renal (n = 3) cancers. The median follow-up was …
Prostate stereotactic body radiotherapy—first UK experience.
Tree AC, Ostler P, Hoskin P, Dankulchai P, Nariyangadu P, Hughes RJ, Wells E, Taylor H, Khoo VS, van As NJ. Tree AC, et al. Among authors: van as nj. Clin Oncol (R Coll Radiol). 2014 Dec;26(12):757-61. doi: 10.1016/j.clon.2014.08.007. Epub 2014 Sep 3. Clin Oncol (R Coll Radiol). 2014. PMID: 25193299
All patients had toxicity International Prostate Symptom score (IPSS) and Radiation Therapy Oncology Group recorded prospectively and prostate-specific antigen was measured 3-6 monthly during follow-up. RESULTS: The median IPSS was 6, 11, 8 and 5 at baseline, 1-3 weeks, 4- …
All patients had toxicity International Prostate Symptom score (IPSS) and Radiation Therapy Oncology Group recorded prospectively and prosta …
Consolidative durvalumab outcomes in stage III non-small cell lung cancer in a multi-centre study.
A K, H S, W H, As F, P WP, A R. A K, et al. Among authors: as f. Cancer Treat Res Commun. 2021;29:100496. doi: 10.1016/j.ctarc.2021.100496. Epub 2021 Nov 27. Cancer Treat Res Commun. 2021. PMID: 34864586 Free article.
RESULTS: Of the total 63 patients, 27 (43%), 16 (25%), 8 (13%), and 12 (19%) patients in the PD-L1 50%, PD-L1 1-49%, PD-L1 <1%, and PD-L1 unknown groups (reported separately), respectively. With the median follow-up of 17.0 months, our multivariable Cox analysis suggest …
RESULTS: Of the total 63 patients, 27 (43%), 16 (25%), 8 (13%), and 12 (19%) patients in the PD-L1 50%, PD-L1 1-49%, PD-L1 <1%, and PD-L1 …
Stereotactic ablative body radiotherapy in patients with oligometastatic cancers: a prospective, registry-based, single-arm, observational, evaluation study.
Chalkidou A, Macmillan T, Grzeda MT, Peacock J, Summers J, Eddy S, Coker B, Patrick H, Powell H, Berry L, Webster G, Ostler P, Dickinson PD, Hatton MQ, Henry A, Keevil S, Hawkins MA, Slevin N, van As N. Chalkidou A, et al. Among authors: van as n. Lancet Oncol. 2021 Jan;22(1):98-106. doi: 10.1016/S1470-2045(20)30537-4. Lancet Oncol. 2021. PMID: 33387498
FINDINGS: Between June 15, 2015, and Jan 30, 2019, 1422 patients were recruited from 17 hospitals in England. The median age of the patients was 69 years (IQR 62-76), and the most common primary tumour was prostate cancer (406 [28.6%] patients). Median follow-up was …
FINDINGS: Between June 15, 2015, and Jan 30, 2019, 1422 patients were recruited from 17 hospitals in England. The median age of the p …
Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.
Henderson DR, de Souza NM, Thomas K, Riches SF, Morgan VA, Sohaib SA, Dearnaley DP, Parker CC, van As NJ. Henderson DR, et al. Among authors: van as nj. Eur Urol. 2016 Jun;69(6):1028-33. doi: 10.1016/j.eururo.2015.10.010. Epub 2015 Oct 21. Eur Urol. 2016. PMID: 26482887
Kaplan-Meier analysis and univariate and multivariate regression analyses were performed. RESULTS AND LIMITATIONS: The median follow-up was 9.5 yr (interquartile range 7.9-10.0 yr). On univariate analysis, ADC below the median was associated with shorter TAH (hazard …
Kaplan-Meier analysis and univariate and multivariate regression analyses were performed. RESULTS AND LIMITATIONS: The median follow- …
49 results